Narcolepsy clinical trials at UCSF
1 in progress, 0 open to eligible people
Showing trials for
ALKS 2680 in Subjects With Narcolepsy Type 2
Sorry, in progress, not accepting new patients
The purpose of this study is to measure the safety and decrease in sleepiness in subjects with narcolepsy type 2 (NT2) when taking ALKS 2680 tablets compared to placebo tablets.
San Francisco 5391959, California 5332921 and other locations
Last updated: